The opportunity for greater patient and public involvement and engagement in drug development and regulation

Patients and the wider public are beneficiaries of scientific research that leads to new drugs and medical technologies, but they can and should be able to contribute to these advances through participation in clinical studies, co-design of research and input into regulatory processes. The key elements of PPIE, proposed by Kathy Oliver, patient advocate and